Home Search Abstracts Browse Oral Sessions Browse Poster Sessions

 

Session 67-Poster Abstracts
Determinants of Slow Progression of HIV Disease
Thursday, 2-4 pm; Poster Hall
      296

Reduced Immune Activation in Course of HTLV-2 Infection Exerts a Protective Role on HIV-1 Replication
E Pilotti1, F Bignami2, F Bozzano3, Massimo Galli*2, A De Maria3, and C Casoli2
1Immigrant Hlth Ctr of Parma, Italy; 2Univ of Milan, Italy; and 3IRCCS, Genoa, Italy
      297 Gut-homing Potential of HIV-specific CD4+ and CD8+ T Cells in HIV-infected Subjects with Slow Disease Progression
Vanessa Wacleche*1, A Gosselin1, P Monteiro1, H Kared1, M-R Boulassel2, J-P Routy2, and P Ancuta1,3
1Ctr Hosp Univ Montreal, Univ of Montreal, Saint-Luc Hosp, Canada; 2Montreal Chest Inst, McGill Univ, Canada; and 3INSERM U743, Montreal, Canada
      298 Sustained CD4 Counts and Preserved Functional CD8 T Cell Responses Are Key Determinants of Natural Control of HIV-1 Infection
Seema Desai*1, R Ronquillo1, P Norris2, E Golub3, R Greenblatt4, S Gange3, and A Landay1
1Rush Univ Med Ctr, Chicago, IL, US; 2Blood Systems Res Inst, San Francisco, CA, US; 3Johns Hopkins Univ Bloomberg Sch of Publ Hlth, Baltimore, MD, US; and 4Univ of California, San Francisco, US
      299

Viral Evolution in HIV-1 Infection Controllers
Yi Liu*1, A Thomas1, H Zhu1, S Ivanov1, J McNevin2, J McElrath2, J Mullins1, H Horton3, and T Zhu1
1Univ of Washington, Seattle, US; 2Vaccine and Infectious Disease Inst, Fred Hutchinson Cancer Res Ctr, Seattle, WA, US; and 3Seattle Biomed Res Inst, WA, US
      300 Determining the Role of APOBEC3 in the Interferon-a Suppression of HIV-1 in vivo
Satish Pillai*1,2, M Abdel-Mohsen1,2, A Monto1,2, K Fujimoto2, W Greene3, A Rauch4, B Ledergerber5, H Gunthard5, J Wong5, and the Swiss HIV Cohort Study
1Univ of California, San Francisco, US; 2VAMC, San Francisco, CA, US; 3Gladstone Inst of Virology and Immunology, San Francisco, CA, US; 4Univ of Bern, Switzerland; and 5Univ Hosp Zurich, Switzerland
      301

Low Replicative Capacity of HIV-1 Envelopes Derived from the Viruses Present in a Super-infected Elite Suppressor Patient
Maria Pernas*1, C Casado1, C Arcones1, E Grau2, L Ruiz2, and C López Galíndez1
1Inst de Salud Carlos III, Madrid, Spain and 2Fndn irsiCaixa, Hosp Univ Germans Trias i Pujol, Badalona, Spain
      302

Disease Progression after Intrasubtype Superinfection in an HLA-B57+ Asymptomatic LTNP Initially Infected with a nef-defective HIV-1 Strain
Martine Braibant*1, J Xie2, A Samri2, H Agut3, B Autran2, and F Barin1
1INSERM U966, Ctr Hosp Res Univ de Tours, Univ Francois-Rabelais, France; 2INSERM U543, Hosp Pitie-Salpetriere, Paris, France; and 3UPRES EA2387, Hosp Pitie-Salpetriere, Paris, France